Edwards Lifesciences Corp. (EW)
86.53
-1.01
(-1.15%)
USD |
NYSE |
May 27, 16:00
86.53
0.00 (0.00%)
After-Hours: 17:39
Edwards Lifesciences Cash from Investing (Quarterly) : -92.80M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | -914.50M |
| Globus Medical, Inc. | -182.67M |
| Abbott Laboratories | -20.32B |
| Boston Scientific Corp. | -591.00M |
| Artivion, Inc. | -10.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 43.80M |
| Cash from Financing (Quarterly) | -451.20M |
| Free Cash Flow | 1.090B |
| Free Cash Flow Per Share (Quarterly) | -0.0363 |
| Free Cash Flow to Equity (Quarterly) | -18.60M |
| Free Cash Flow to Firm (Quarterly) | -21.10M |
| Free Cash Flow Yield | 2.16% |